of the disease group, the clinical data of the above groups were retrospectively analyzed. Serum 5 mL of fasting venous blood was collected from the above groups of patients and the serum was separated. The expression of CXCL-13, VEGF, CCL-18, EGF, SP-A, SP-D and KL-6 in serum was detected by ELISA. The differences of serum markers in each group were analyzed, and the sensitivity and specificity of each serum markers were compared.
Results: the levels of serum KL-6, SP-A, SP-D, EGF, VEGF, CCL18, and CXCL13 in the IPF group were significantly higher than those in the healthy control group. there were differences in the expression levels of serum markers in the Asthma group, the COPD group, and the remaining serum markers were lower than the IPF group except CCL18. According to the ROC curve, the sensitivity of EGF>CXCL-13>KL-6>SP-D>SP-A>VEGF>CCL18 was evaluated in each of the biological parameters of IPF patients.
When the seven markers were combined, the AUC value measured was largest, and the AUC value between the combined marker and each single marker was statistically significant.
Conclusion: the 7 serum markers are of certain significance for the early diagnosis of IPF. The combined serum markers are more sensitive and specific than the single markers for the diagnosis of IPF, and have higher cost benefit for the management of IPF patients. Methods: We report the case of a 73-year-old woman who had commenced treatment with oral bepridil 4 months earlier and subsequently developed cough and difficulty in breathing more than 1 month prior to presentation.
Results: Initial evaluation at our department revealed infiltrative shadows in both lung fields on chest-computed tomography. Serum KL-6 levels were 10,570 U/mL. A drug-induced lymphocyte stimulation test (DLST) was negative. Bronchoscopy and bronchoalveolar lavage fluid analysis revealed 41% lymphocyte cell subpopulations. Based on a high index of suspicion of drug-induced lung injury due to bepridil oral administration was stopped immediately, resulting in spontaneous resolution of symptoms. A repeat DLST performed 1 year after drug discontinuation was positive.
Conclusion:
We report this as a rare case of spontaneous resolution of symptoms in which DLST became positive after discontinuation of the drug. Background and Aims: Carbon ion radiotherapy (CIRT) has been expected to be an alternative for surgery for early-stage non-small-cell lung cancer (NSCLC) and adopted as the second-best choice even in operable patients. Recently, NSCLC with ground glass opacity (GGO) dominant image has been reported as a less invasive. The purpose of this study was to investigate the demographic data, perioperative courses and therapeutic outcomes of patients who underwent CIRT for patients with early-stage NSCLC showing GGO dominant shadow. Results: There were 13 men and 1 women, whose mean age was 75 (60-85) years old at the time of hospitalization for CIRT. The average major axis of the tumor was 25 (16-44) mm; on the other hand, the mean solid part was 4.7 (0-22) mm. All the tumours were pathologically diagnosed as adenocarcinoma. The clinical stages before CIRT with NSCLC were as follows: 2 TisN0M0, 6 TmiN0M0, 5 T1aN0M0 and 1 T1cN0M0. Three of the 14 patients were inoperable because of poor respiratory function (n = 2) or chronic heart failure (n = 1), or the other patients were operable, but refused surgery and selected CIRT. The average CIRT 
